Physician profile
Ashish Sud
NPI 1568583334
$1,079.55
in general payments reported to CMS, 2019-2025
10 companies · $358 in 2025
The $358 reported for 2025 was more than what 88% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $65.43 · 2021: $22.14 · 2022: $142 · 2023: $84.91 · 2024: $123 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.19 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $285.97 | 2021-2025 | On-Q Pump and Accessories |
| Mallinckrodt Enterprises LLC | $213.88 | 2019 | |
| Merck Sharp & Dohme LLC | $173.45 | 2019-2025 | Bridion |
| Stryker Corporation | $103.27 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Baxter Healthcare | $80.51 | 2022-2024 | Preveleak, Floseal, Coseal |
| Mallinckrodt Hospital Products INC. | $65.43 | 2020 | |
| Octapharma USA, INC. | $58.30 | 2025 | Fibryga |
| Eagle Pharmaceuticals, INC. | $56.96 | 2023 | |
| Becton, Dickinson and Company | $25.13 | 2025 | Hemosphere |
| Haemonetics Corporation | $16.65 | 2025 | Teg6s Hemostasis System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Sud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.